ABOUT US

HighCape is a growth equity fund with a unique, multidisciplinary team of savvy executives. With decades of business success, HighCape transforms outstanding medical technology companies into sustainable businesses.

founded

investments completed

employees

million annual revenue

Learn more

PORTFOLIO

Our portfolio size is intentionally small so we can dedicate the time and effort 
required to customize our investment strategy to address the specific needs of each company. Through these investments, we create scalable, revenue-generating 
entities with multiple exit alternatives.

TELA Bio
Aziyo Biologics
Wellinks
Zipline Medical
Cheetah Medical
Read more

CASE STUDIES

We are passionate about building companies and have a track record of success in delivering value to our investment partners and the healthcare system. See how our investment strategy has transformed companies and realized outsized returns.

Case Studies

LATEST NEWS

Wellinks Announces Initiation of IRB Approved Study of Digital Health Solution for COPD read more
Athena Therapeutics announces initial financing from Highcape Capital and Connecticut Innovations read more
Aziyo Biologics Reports Third Quarter 2020 Financial Results read more
Aziyo Biologics to Participate in the Piper 32nd Annual Virtual Healthcare Conference read more
title read more
See more articles

CONTACT US

Could HighCape be the right partner for your growing business?
Contact us for more information.

452 5th Ave, 21st Floor
New York, NY 10018